Search results
7 sie 2023 · Explain the treatment and management options available for chronic obstructive pulmonary disease (COPD). Discuss interprofessional team strategies for improving care coordination and communication to advance chronic obstructive pulmonary disease (COPD) and improve outcomes.
12 lut 2021 · We discuss the pathophysiology of COPD; describe COPD risk factors, signs, and symptoms that may facilitate earlier diagnosis of COPD; and reinforce the importance of spirometry use in establishing the diagnosis of COPD.
2 lut 2020 · Chronic obstructive pulmonary disease (COPD) is a preventable and treatable disease with airway obstruction and is characterized by persistent respiratory symptoms. 1 COPD is estimated to affect about 16 million adults in the United States. 2 Incidence of COPD is highest in patients who smoke or have a history of tobacco use, those older than ...
7 sie 2023 · Publication types. Study Guide. Chronic obstructive pulmonary disease (COPD) is a common and treatable disease characterized by progressive airflow limitation and tissue destruction. It is associated with structural lung changes due to chronic inflammation from prolonged exposure to noxious particles or gases most commonly cigaret ….
1 maj 2020 · Abstract. Background: This document provides clinical recommendations for the pharmacologic treatment of chronic obstructive pulmonary disease (COPD). It represents a collaborative effort on the part of a panel of expert COPD clinicians and researchers along with a team of methodologists under the guidance of the American Thoracic Society.
11 cze 2022 · Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity, mortality, and health-care use worldwide. COPD is caused by exposure to inhaled noxious particles, notably tobacco smoke and pollutants.
1 maj 2020 · Abstract. Background: This document provides clinical recommendations for the pharmacologic treatment of chronic obstructive pulmonary disease (COPD). It represents a collaborative effort on the part of a panel of expert COPD clinicians and researchers along with a team of methodologists under the guidance of the American Thoracic Society.
